Moderna's recent success in a phase 3 clinical trial for its personalized cancer vaccine was a breakthrough. This product could rival the lifetime sales of Moderna's coronavirus vaccine. Moderna's ...
CAMBRIDGE, Mass., August 27, 2026 (Newswire.com) - Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA recently approved updated 2026-2027 COVID-19 vaccines from Moderna, Pfizer-BioNTech, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...